AKT1 and neurodevelopmental disorder: This suggests that the development of future therapies aimed at specifically targeting PPP2R5D-dependent effects on AKT/mTOR signaling in PPP2R5D-related neurodevelopmental disorder should be mindful of potential salutary effects.